153 related articles for article (PubMed ID: 10818677)
21. The role of hepatocyte growth factor (scatter factor) in epithelial-mesenchymal transition and breast cancer.
Elliott BE; Hung WL; Boag AH; Tuck AB
Can J Physiol Pharmacol; 2002 Feb; 80(2):91-102. PubMed ID: 11934261
[TBL] [Abstract][Full Text] [Related]
22. Hepatocyte growth factor/scatter factor, liver regeneration and cancer metastasis.
Jiang WG; Hallett MB; Puntis MC
Br J Surg; 1993 Nov; 80(11):1368-73. PubMed ID: 8252338
[TBL] [Abstract][Full Text] [Related]
23. Role of HGF/c-met system in invasion and metastasis of oral squamous cell carcinoma cells in vitro and its clinical significance.
Uchida D; Kawamata H; Omotehara F; Nakashiro Ki ; Kimura-Yanagawa T; Hino S; Begum NM; Hoque MO; Yoshida H; Sato M; Fujimori T
Int J Cancer; 2001 Aug; 93(4):489-96. PubMed ID: 11477552
[TBL] [Abstract][Full Text] [Related]
24. Abnormality of the hepatocyte growth factor/MET pathway in pulmonary adenocarcinogenesis.
Tachibana K; Minami Y; Shiba-Ishii A; Kano J; Nakazato Y; Sato Y; Goya T; Noguchi M
Lung Cancer; 2012 Feb; 75(2):181-8. PubMed ID: 21872356
[TBL] [Abstract][Full Text] [Related]
25. Involvement of HGF/SF-Met signaling in prostate adenocarcinoma cells: evidence for alternative mechanisms leading to a metastatic phenotype in Pr-14c.
MacDougall CA; Vargas M; Soares CR; Holzer RG; Ide AE; Jorcyk CL
Prostate; 2005 Jul; 64(2):139-48. PubMed ID: 15678502
[TBL] [Abstract][Full Text] [Related]
26. CD44-independent hepatocyte growth factor/c-Met autocrine loop promotes malignant peripheral nerve sheath tumor cell invasion in vitro.
Su W; Gutmann DH; Perry A; Abounader R; Laterra J; Sherman LS
Glia; 2004 Feb; 45(3):297-306. PubMed ID: 14730703
[TBL] [Abstract][Full Text] [Related]
27. The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis.
You WK; McDonald DM
BMB Rep; 2008 Dec; 41(12):833-9. PubMed ID: 19123972
[TBL] [Abstract][Full Text] [Related]
28. Isolation and Characterization of a Chinese Hamster Ovary Heparan Sulfate Cell Mutant Defective in Both Met Receptor Binding and Hepatocyte Growth Factor NK1/Met Signaling.
Cao T; Pan J; Li X; He Y; Jiang Y; Chang Y; Zhang Q; Lan Y; Wang H; Jiao W; Tian Z; Zhang L
Cell Physiol Biochem; 2018; 48(4):1480-1491. PubMed ID: 30107380
[TBL] [Abstract][Full Text] [Related]
29. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.
Matsumoto K; Nakamura T; Sakai K; Nakamura T
Proteomics; 2008 Aug; 8(16):3360-70. PubMed ID: 18646008
[TBL] [Abstract][Full Text] [Related]
30. Molecular characteristics of HGF-SF and its role in cell motility and invasion.
Weidner KM; Hartmann G; Naldini L; Comoglio PM; Sachs M; Fonatsch C; Rieder H; Birchmeier W
EXS; 1993; 65():311-28. PubMed ID: 8380739
[TBL] [Abstract][Full Text] [Related]
31. [Physiologic and physiopathologic role of hepatocyte growth factor].
RodrÃguez-Fragoso L
Rev Invest Clin; 1998; 50(4):355-67. PubMed ID: 9830326
[TBL] [Abstract][Full Text] [Related]
32. Hepatocyte growth factor exerts multiple biological functions on bovine mammary epithelial cells.
Accornero P; Martignani E; Macchi E; Baratta M
J Dairy Sci; 2007 Sep; 90(9):4289-96. PubMed ID: 17699048
[TBL] [Abstract][Full Text] [Related]
33. From Tpr-Met to Met, tumorigenesis and tubes.
Peschard P; Park M
Oncogene; 2007 Feb; 26(9):1276-85. PubMed ID: 17322912
[TBL] [Abstract][Full Text] [Related]
34. Osthole suppresses hepatocyte growth factor (HGF)-induced epithelial-mesenchymal transition via repression of the c-Met/Akt/mTOR pathway in human breast cancer cells.
Hung CM; Kuo DH; Chou CH; Su YC; Ho CT; Way TD
J Agric Food Chem; 2011 Sep; 59(17):9683-90. PubMed ID: 21806057
[TBL] [Abstract][Full Text] [Related]
35. HGF/c-MET targeted therapeutics: novel strategies for cancer medicine.
Yap TA; Sandhu SK; Alam SM; de Bono JS
Curr Drug Targets; 2011 Dec; 12(14):2045-58. PubMed ID: 21777195
[TBL] [Abstract][Full Text] [Related]
36. Hepatocyte growth factor (HGF) induces invasion of endometrial carcinoma cell lines in vitro.
Bae-Jump V; Segreti EM; Vandermolen D; Kauma S
Gynecol Oncol; 1999 May; 73(2):265-72. PubMed ID: 10329045
[TBL] [Abstract][Full Text] [Related]
37. Met-HGF/SF: tumorigenesis, invasion and metastasis.
Vande Woude GF; Jeffers M; Cortner J; Alvord G; Tsarfaty I; Resau J
Ciba Found Symp; 1997; 212():119-30; discussion 130-2, 148-54. PubMed ID: 9524767
[TBL] [Abstract][Full Text] [Related]
38. Hepatocyte growth factor is essential for migration of myogenic cells and promotes their proliferation during the early periods of tongue morphogenesis in mouse embryos.
Amano O; Yamane A; Shimada M; Koshimizu U; Nakamura T; Iseki S
Dev Dyn; 2002 Mar; 223(2):169-79. PubMed ID: 11836782
[TBL] [Abstract][Full Text] [Related]
39. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.
Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M
Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631
[TBL] [Abstract][Full Text] [Related]
40. Expression of the met-receptor and its ligand, HGF-SF during mouse embryogenesis.
Sonnenberg E; Weidner KM; Birchmeier C
EXS; 1993; 65():381-94. PubMed ID: 8380744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
